Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease.
Overview
- Department of Geriatrics, Maoming People’s Hospital, Maoming, Guangdong China
- Guangzhou Medical University, Guangzhou, Guangdong China
- Department of Oncology I, Maoming People’s Hospital, Maoming, Guangdong China
- Department of Emergency, Guangdong Provincial Farm Reclamation Central Hospital, Zhanjiang, Guangdong China
- Department of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong China
Abstract
Neuroprotective effects of statins in Parkinson’s disease (PD) remain uncertain, and their activity in genetic α-synuclein (αSyn) disease models has been insufficiently characterized. We evaluated atorvastatin (ATO) in a mouse model with nigral overexpression of human A53T-mutant αSyn. Mice received ATO by oral gavage at 10 mg/
Supplementary Information: The online version contains supplementary material available at https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- uniprot.org/
uniprotkb , at UniProt; found in the text, “Molecular Docking”
Data Availability
All data collections employed and analyzed for the purposes of this research are available from the corresponding author on request from qualified investigators.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 3, 28 September 2026
- Publisher: n/a → Springer Science+Business Media
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 5 keywords, 12 MeSH terms, 2 funders, 37 references.
Cite
This paper
Wei, L., Hua, J., Tang, S., Lei, J., Li, G., Wei, L., & Mo, M. (2026). Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease. Neurotoxicity research, 44(5), 51. https://
BibTeX
@article{wei2026atorvast
author = {Wei, Lijian and Hua, Junkai and Tang, Shuangfeng and Lei, Jianming and Li, Guozhi and Wei, LiWei and Mo, MingShu},
title = {{Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease}},
journal = {Neurotoxicity research},
year = {2026},
month = sep,
volume = {44},
number = {5},
pages = {51},
publisher = {Springer Science+Business Media},
issn = {1029-8428},
doi = {10.1007/
url = {https://
pmid = {42714756},
pmcid = {PMC13558405}
}
RIS
TY - JOUR
AU - Wei, Lijian
AU - Hua, Junkai
AU - Tang, Shuangfeng
AU - Lei, Jianming
AU - Li, Guozhi
AU - Wei, LiWei
AU - Mo, MingShu
TI - Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease
T2 - Neurotoxicity research
J2 - Neurotox Res
PY - 2026
DA - 2026/
VL - 44
IS - 5
SP - 51
SN - 1029-8428
PB - Springer Science+Business Media
DO - 10.1007/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1007/
"type": "article-journal",
"title": "Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease",
"container-title": "Neurotoxicity research",
"author": [
{
"family": "Wei",
"given": "Lijian"
},
{
"family": "Hua",
"given": "Junkai"
},
{
"family": "Tang",
"given": "Shuangfeng"
},
{
"family": "Lei",
"given": "Jianming"
},
{
"family": "Li",
"given": "Guozhi"
},
{
"family": "Wei",
"given": "LiWei"
},
{
"family": "Mo",
"given": "MingShu"
}
],
"container-title-short":
"volume": "44",
"issue": "5",
"page": "51",
"DOI": "10.1007/
"PMID": "42714756",
"PMCID": "PMC13558405",
"ISSN": "1029-8428",
"publisher": "Springer Science+Business Media",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
9,
9
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s13024-026-00951-3
- Cholesterol metabolism in neurodegenerative diseases: mechanisms and therapeutic advances.Journal: Molecular neurodegenerationIn common: cellular / molecular, 3 references
- [2] doi:10.1186/s13024-025-00923-z [code]
- Two lysosomal genes ATP13A2 and GBA1 interact to drive neurodegeneration.Journal: Molecular neurodegenerationIn common: Parkinson's, genetics / omics, cellular / molecular, 3 references
- [3] doi:10.1186/s40246-025-00898-4 [code]
- Prioritizing missense mutations via a deep learning phosphorylation prediction model.Journal: Human genomicsIn common: uniprot.org/uniprotkb, Parkinson's, genetics / omics, cellular / molecular
- [4] doi:10.1093/brain/awag039 [code]
- Mapping the causal chain from genetic risk variants to lipid dysmetabolism in Parkinson's disease.Journal: Brain : a journal of neurologyIn common: Parkinson's, genetics / omics, 3 references
- [5] doi:10.1016/j.chom.2024.02.011 [code]
- Pathophysiology of chikungunya virus infection associated with fatal outcomes.Journal: Cell host & microbeIn common: uniprot.org/uniprotkb, genetics / omics, cellular / molecular
- [6] doi:10.3390/cells15151379
- Extracellular Aβ42 Oligomers Induce ROCK2 Hyperactivation Through Dual Mediation by RhoA and GzmB: Significance of Moderate ROCK2 Activity in Neural Cells.Journal: CellsIn common: uniprot.org/uniprotkb, mouse, cellular / molecular
- [7] doi:10.1016/j.xcrm.2024.101546
- Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.Journal: Cell reports. MedicineIn common: uniprot.org/uniprotkb, mouse, cellular / molecular
- [8] doi:10.1038/s41467-024-50183-6
- The mouse multi-organ proteome from infancy to adulthood.Journal: Nature communicationsIn common: uniprot.org/uniprotkb, genetics / omics, mouse
- [9] doi:10.1007/s10571-026-01706-w
- Nitric Oxide Donor Alleviates Cardiac Arrest Induced Blood Brain Barrier Injury by Inhibiting HMGB1-ATG5 Mediated Endothelial Autophagy.Journal: Cellular and molecular neurobiologyIn common: uniprot.org/uniprotkb, mouse, cellular / molecular
- [10] doi:10.3390/ph18101456
- Shentong Zhuyu Decoction Alleviates Neuropathic Pain in Mice by Inhibiting the NMDAR-2B Receptor-Mediated CaMKII/
CREB Signaling Pathway in GABAergic Neurons of the Interpeduncular Nucleus. Journal: Pharmaceuticals (Basel, Switzerland)In common: uniprot.org/uniprotkb, mouse, cellular / molecular
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
